Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Go back to Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress| (NASDAQ: RVMD) | Delayed: 168.70 +2.89 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $165.81 | 52 Week High | $ | |||
| Open | $163.30 | 52 Week Low | $ | |||
| Day High | $171.25 | P/E | N/A | |||
| Day Low | $163.05 | EPS | $ | |||
| Volume | 1,829,017 | |||||

